The Wall Street Journal reports that Pfizer's new CEO, Jeffrey Kindler (photo), is preparing to announce new job cuts on Monday, as he steps up the company's restructuring efforts. As part of the new approach, Kindler is evidently looking at containing R&D expenses while making cuts in marketing and administration. At the same time, company insiders tell the JoIurnal that Kindler is considering reorganizing scientists into disease groups, in order to hold the company's scientists accountable for their results.
- here's the article from The Wall Street Journal (sub. req.)
What's next for Pfizer? Report
Pfizer to axe 2,200 sales jobs in realignment. Report
Pfizer's Kindler leaves analysts feeling flat. Report
CEO McKinnell gets the boot as Pfizer struggles. Report